Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
Counterfeiting can apply to both branded and generic products, with counterfeit products including drugs with the correct ingredients or with the wrong ingredients; without active ingredients, with insufficient active ingredient or with fake packaging. The increased occurrence of counterfeit medicines has several serious consequences.
These may include illness or death of patients, higher medical insurance and lost revenues to pharmaceutical manufacturers and governments. Children are particularly at risk. Diminished public confidence in both health care providers and the medicines supply chain could indirectly lead to increased illness (as a result of non-adherence) which would strain health care services. Damage to a brand’s credibility could tarnish a manufacturer’s reputation, not to forget the substantial loss of revenues.
The recent discovery of counterfeit medicines in the UK supply chain prompted Professor Moffat, Dr O’Neil and their colleagues at the Centre for Pharmaceutical Analysis, The School of Pharmacy, University of London, to develop a rapid, precise and portable analytical technique for in-field use.
Working with samples provided by the Korean Food and Drugs Agency and a portable transmittance near infrared (NIR) spectrometer developed by NIR Technology Systems they have the answer to identifying counterfeits where they choose. This ability to replace laboratory analysis with the use of a portable instrument at the point of sampling is an attractive option for regulatory authorities. Furthermore, the NIR technique is rapid, precise, non-destructive and costs very little to operate.
Their findings have been published in the latest edition of the Journal of Near Infrared Spectroscopy. “Near infrared spectroscopy is a scientific tool which has helped us understand the differences between genuine and counterfeit drugs, even those which look exactly the same to the naked eye,” Professor Moffat said.
As well as being able to identify counterfeit from genuine tablets, the chemical information provided by NIR spectroscopy helps identify the likely origin of the tablet. Thus law enforcement agencies obtain valuable information about the laboratories manufacturing counterfeit medicines.
The present paper was presented at the 13th International Conference on Near Infrared Spectroscopy in Umeå, Sweden. Professor Moffat, together with his students and collaborators, are also developing the technique of NIR spectroscopy for the quality assurance of medicines and to ensure that manufacturing methods are efficient and effective. “Our studies also have relevance to the formulation development of new medicines to make sure that patients get the right drug at the right amount at the right time”, said Professor Moffat.
Ian Michael | alfa
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Materials Sciences
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering